Sorry, you need to enable JavaScript to visit this website.

NIMENRIX (Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine) Health Professional Information

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Health Professional Information

SUMMARY PRODUCT INFORMATION

 

1conjugated to tetanus toxoid carrier protein 44 micrograms

Route of Administration

Dosage Form / Strength

Clinically Relevant Nonmedicinal Ingredients

Intramuscular Injection

Powder and diluent for solution for injection

Neisseria meningitidis serogroup A polysaccharide1
5 micrograms

Neisseria meningitidis serogroup C polysaccharide1
5 micrograms

Neisseria meningitidis serogroup W-135 polysaccharide1
5 micrograms

Neisseria meningitidis serogroup Y polysaccharide1
5 micrograms

Sucrose

Trometamol

Sodium chloride

For a complete listing see Dosage Forms, Composition and Packaging section.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111